Requirement of GTP binding for TIF-90-regulated ribosomal RNA synthesis and oncogenic activities in human colon cancer cells.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
10 2020
Historique:
received: 05 08 2019
accepted: 13 02 2020
pubmed: 12 3 2020
medline: 5 3 2021
entrez: 12 3 2020
Statut: ppublish

Résumé

Transcription initiation factor 90 (TIF-90), an alternatively spliced variant of TIF-IA, differs by a 90 base pair deletion of exon 6. TIF-90 has been shown to regulate ribosomal RNA (rRNA) synthesis by interacting with polymerase I (Pol I) during the initiation of ribosomal DNA (rDNA) transcription in the nucleolus. Recently, we showed that TIF-90-mediated rRNA synthesis can play an important role in driving tumorigenesis in human colon cancer cells. Here we show that TIF-90 binds GTP at threonine 310, and that GTP binding is required for TIF-90-enhanced rRNA synthesis. Overexpression of activated AKT induces TIF-90 T310, but not a GTP-binding site (TIF-90 T310N) mutant, to translocate into the nucleolus and increase rRNA synthesis. Complementing this result, treatment with mycophenolic acid (MPA), an inhibitor of GTP production, dissociates TIF-90 from Pol I and hence abolishes AKT-increased rRNA synthesis by way of TIF-90 activation. Thus, TIF-90 requires bound GTP to fulfill its function as an enhancer of rRNA synthesis. Both TIF variants are highly expressed in colon cancer cells, and depletion of TIF-IA expression in these cells results in significant sensitivity to MPA-inhibited rRNA synthesis and reduced cell proliferation. Finally, a combination of MPA and AZD8055 (an inhibitor of both AKT and mTOR) synergistically inhibits rRNA synthesis, in vivo tumor growth, and other oncogenic activities of primary human colon cancer cells, suggesting a potential avenue for the development of therapeutic treatments by targeting the regulation of rRNA synthesis by TIF proteins.

Identifiants

pubmed: 32159236
doi: 10.1002/jcp.29661
doi:

Substances chimiques

DNA, Ribosomal 0
RNA, Ribosomal 0
Transcription Factors 0
Guanosine Triphosphate 86-01-1
RNA Polymerase I EC 2.7.7.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7567-7579

Subventions

Organisme : National Foundation for Science and Technology Development
ID : 106-YS.02-2015.60

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

Andersen, J. S., Lam, Y. W., Leung, A. K. L., Ong, S. E., Lyon, C. E., Lamond, A. I., & Mann, M. (2005). Nucleolar proteome dynamics. Nature, 433, 77-83.
Barker, M. M., & Gourse, R. L. (2001). Regulation of rRNA transcription correlates with nucleoside triphosphate sensing. Journal of Bacteriology, 183, 6315-6323.
Bierhoff, H., Dundr, M., Michels, A. A., & Grummt, I. (2008). Phosphorylation by casein kinase 2 facilitates rRNA gene transcription by promoting dissociation of TIF-IA from elongating RNA polymerase I. Molecular and Cellular Biology, 28, 4988-4998.
Blattner, C., Jennebach, S., Herzog, F., Mayer, A., Cheung, A. C. M., Witte, G., … Cramer, P. (2011). Molecular basis of Rrn3-regulated RNA polymerase I initiation and cell growth. Genes and Development, 25, 2093-2105.
Bodem, J., Dobreva, G., Hoffmann-Rohrer, U., Iben, S., Zentgraf, H., Delius, H., … Grummt, I. (2000). TIF-IA, the factor mediating growth-dependent control of ribosomal RNA synthesis, is the mammalian homolog of yeast Rrn3p. EMBO Reports, 1, 171-175.
Boisvert, F. M., van Koningsbruggen, S., Navascues, J., & Lamond, A. I. (2007). The multifunctional nucleolus. Nature Reviews Molecular Cell Biology, 8, 574-585.
Burger, K., Mühl, B., Harasim, T., Rohrmoser, M., Malamoussi, A., Orban, M., … Eick, D. (2010). Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. Journal of Biological Chemistry, 285, 12416-12425.
Choong, M. L., Yang, H., Lee, M. A., & Lane, D. P. (2009). Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy. Cell Cycle, 8, 2810-2818.
Correll, C. C., Bartek, J., & Dundr, M. (2019). The nucleolus: A multiphase condensate balancing ribosome synthesis and translational capacity in health, aging and ribosomopathies. Cells, 8, 869.
Filomeni, G., De Zio, D., & Cecconi, F. (2015). Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death and Differentiation, 22, 377-388.
Grummt, I. (2003). Life on a planet of its own: Regulation of RNA polymerase I transcription in the nucleolus. Genes and Development, 17, 1691-1702.
Hoppe, S., Bierhoff, H., Cado, I., Weber, A., Tiebe, M., Grummt, I., & Voit, R. (2009). AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proceedings of the National Academy of Sciences of the United States of America, 106, 17781-17786.
Huang, M., Ji, Y., Itahana, K., Zhang, Y., & Mitchell, B. (2008). Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. Leukemia Research, 32, 131-141.
Kasahara, A., & Scorrano, L. (2014). Mitochondria: From cell death executioners to regulators of cell differentiation. Trends in Cell Biology, 24, 761-770.
Leipe, D. D., Wolf, Y. I., Koonin, E. V., & Aravind, L. (2002). Classification and evolution of P-loop GTPases and related ATPases. Journal of Molecular Biology, 317, 41-72.
Mayer, C., Bierhoff, H., & Grummt, I. (2005). The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. Genes and Development, 19, 933-941.
Mayer, C., Zhao, J., Yuan, X., & Grummt, I. (2004). mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes and Development, 18, 423-434.
Nguyen, D. Q., Hoang, D. H., Nguyen, T. T. V., Ho, H. D., Huynh, V., Shin, J. H., … Nguyen, L. X. T. (2019). Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis. Journal of Cellular Physiology, 234, 17612-17621.
Nguyen, D. Q., Hoang, D. H., Nguyen Vo, T. T., Huynh, V., Ghoda, L., Marcucci, G., & Nguyen, L. X. T. (2018). The role of ErbB3 binding protein 1 in cancer: Friend or foe? Journal of Cellular Physiology, 233, 9110-9120.
Nguyen le, X. T., Chan, S. M., Ngo, T. D., Raval, A., Kim, K. K., Majeti, R., & Mitchell, B. S. (2014). Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells. Blood, 124, 579-589.
Nguyen le, X. T., Lee, Y., Urbani, L., Utz, P. J., Hamburger, A. W., Sunwoo, J. B., & Mitchell, B. S. (2015). Regulation of ribosomal RNA synthesis in T cells: Requirement for GTP and Ebp1. Blood, 125, 2519-2529.
Nguyen le, X. T., & Mitchell, B. S. (2013). Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA. Proceedings of the National Academy of Sciences of the United States of America, 110, 20681-20686.
Nguyen le, X. T., Raval, A., Garcia, J. S., & Mitchell, B. S. (2015). Regulation of ribosomal gene expression in cancer. Journal of Cellular Physiology, 230, 1181-1188.
Nguyen le, X. T., Zhu, L., Lee, Y., Ta, L., & Mitchell, B. S. (2016). Expression and role of the ErbB3-binding protein 1 in acute myelogenous leukemic cells. Clinical Cancer Research, 22, 3320-3327.
Raska, I., Koberna, K., Malinsky, J., Fidlerova, H., & Masata, M. (2004). The nucleolus and transcription of ribosomal genes. Biology of the Cell, 96, 579-594.
Shimobayashi, M., & Hall, M. N. (2014). Making new contacts: The mTOR network in metabolism and signalling crosstalk. Nature Reviews Molecular Cell Biology, 15, 155-162.
Tang, X., Zha, L., Li, H., Liao, G., Huang, Z., Peng, X., & Wang, Z. (2017). Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway. Oncology Reports, 38, 2023-2032.
Zajkowicz, A., Gdowicz-Klosok, A., Krzesniak, M., Scieglinska, D., & Rusin, M. (2015). Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin. Cellular Signalling, 27, 1677-1687.
Zhang, J. X., Mai, S. J., Huang, X. X., Wang, F. W., Liao, Y. J., Lin, M. C., … Xie, D. (2014). MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of beta-catenin signaling. Annals of Oncology, 25, 2196-2204.
Zhao, J., Yuan, X., Frodin, M., & Grummt, I. (2003). ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Molecular Cell, 11, 405-413.

Auteurs

Dang Quan Nguyen (DQ)

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Dinh Hoa Hoang (DH)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Michael Nelson (M)

Light Microscopy Core, City of Hope Medical Center, Duarte, California.

Lokesh Nigam (L)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Vo Thanh Thao Nguyen (VTT)

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Lianjun Zhang (L)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Tram Kim Thi Pham (TKT)

Department of Medical Biotechnology, Biotechnology Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Huu Duc Ho (HD)

Department of Gastrointestinal Surgery, Thong Nhat Hospital, Ho Chi Minh City, Vietnam.

Dai Dong Thi Nguyen (DDT)

Department of Oncology, Thong Nhat Hospital, Ho Chi Minh City, Vietnam.

Trung Quoc Lam (TQ)

Department of Radiation Oncology, University Medical Center of Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Trinh To Tat (TT)

Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas.

Yasmin Elhajmoussa (Y)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Quoc Trung Ly (QT)

Department of Health of Soc Trang province, Soc Trang, Vietnam.

Flavia Pichiorri (F)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Vinod Pullarkat (V)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Bin Zhang (B)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Ya-Huei Kuo (YH)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Guido Marcucci (G)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Le Xuan Truong Nguyen (LXT)

Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH